164 related articles for article (PubMed ID: 16160468)
1. CD4(+) CD56(+) lineage-negative malignancies are rare tumors of plasmacytoid dendritic cells.
Reichard KK; Burks EJ; Foucar MK; Wilson CS; Viswanatha DS; Hozier JC; Larson RS
Am J Surg Pathol; 2005 Oct; 29(10):1274-83. PubMed ID: 16160468
[TBL] [Abstract][Full Text] [Related]
2. Plasmacytoid dendritic cell leukemia in children.
Hama A; Kudo K; Itzel BV; Muramatsu H; Nishio N; Yoshida N; Takahashi Y; Yagasaki H; Ito M; Kojima S
J Pediatr Hematol Oncol; 2009 May; 31(5):339-43. PubMed ID: 19415013
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological analysis of 46 cases with CD4
Suzuki Y; Kato S; Kohno K; Satou A; Eladl AE; Asano N; Kono M; Kato Y; Taniwaki M; Akiyama M; Nakamura S
Histopathology; 2017 Dec; 71(6):972-984. PubMed ID: 28795410
[TBL] [Abstract][Full Text] [Related]
4. Clinical and biologic features of CD4(+)CD56(+) malignancies.
Feuillard J; Jacob MC; Valensi F; Maynadié M; Gressin R; Chaperot L; Arnoulet C; Brignole-Baudouin F; Drénou B; Duchayne E; Falkenrodt A; Garand R; Homolle E; Husson B; Kuhlein E; Le Calvez G; Sainty D; Sotto MF; Trimoreau F; Béné MC
Blood; 2002 Mar; 99(5):1556-63. PubMed ID: 11861268
[TBL] [Abstract][Full Text] [Related]
5. CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells.
Jacob MC; Chaperot L; Mossuz P; Feuillard J; Valensi F; Leroux D; Béné MC; Bensa JC; Brière F; Plumas J
Haematologica; 2003 Aug; 88(8):941-55. PubMed ID: 12935983
[TBL] [Abstract][Full Text] [Related]
6. Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms.
Jaye DL; Geigerman CM; Herling M; Eastburn K; Waller EK; Jones D
Mod Pathol; 2006 Dec; 19(12):1555-62. PubMed ID: 16998465
[TBL] [Abstract][Full Text] [Related]
7. [Clinical Characteristics of CD4
He HS; Wei YF; Ji XY; Xu YH; Yang YQ; Jin XK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):588-594. PubMed ID: 38660871
[TBL] [Abstract][Full Text] [Related]
8. CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Français d'Etude des Lymphomes Cutanés (GFELC).
Petrella T; Dalac S; Maynadié M; Mugneret F; Thomine E; Courville P; Joly P; Lenormand B; Arnould L; Wechsler J; Bagot M; Rieux C; Bosq J; Avril MF; Bernheim A; Molina T; Devidas A; Delfau-Larue MH; Gaulard P; Lambert D
Am J Surg Pathol; 1999 Feb; 23(2):137-46. PubMed ID: 9989839
[TBL] [Abstract][Full Text] [Related]
9. Acute Myeloid Leukemia With MLL Rearrangement and CD4+/CD56+ Expression can be Misdiagnosed as Blastic Plasmacytoid Dendritic Cell Neoplasm: Two Case Reports.
Lee JM; Kim IS; Lee JN; Park SH; Kim HH; Chang CL; Lee EY; Kim HR; Oh SH; Song SA
Ann Lab Med; 2016 Sep; 36(5):494-7. PubMed ID: 27374717
[No Abstract] [Full Text] [Related]
10. [Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic study].
Sang W; Wang CF; Cheng YF; Liu X; Li XX; Gulinar A; Li JZ; Zhang W
Zhonghua Bing Li Xue Za Zhi; 2012 May; 41(5):326-30. PubMed ID: 22883672
[TBL] [Abstract][Full Text] [Related]
11. Immunophenotypic CD56 Variation Within a Single Patient With Blastic Plasmacytoid Dendritic Cell Neoplasm.
Lopez AT; Shaw KS; Yamany T; Husain S; Geskin L
JAMA Dermatol; 2018 Apr; 154(4):492-494. PubMed ID: 29490374
[No Abstract] [Full Text] [Related]
12. 'Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes.
Petrella T; Comeau MR; Maynadié M; Couillault G; De Muret A; Maliszewski CR; Dalac S; Durlach A; Galibert L
Am J Surg Pathol; 2002 Jul; 26(7):852-62. PubMed ID: 12131152
[TBL] [Abstract][Full Text] [Related]
13. Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells.
Garnache-Ottou F; Chaperot L; Biichle S; Ferrand C; Remy-Martin JP; Deconinck E; de Tailly PD; Bulabois B; Poulet J; Kuhlein E; Jacob MC; Salaun V; Arock M; Drenou B; Schillinger F; Seilles E; Tiberghien P; Bensa JC; Plumas J; Saas P
Blood; 2005 Feb; 105(3):1256-64. PubMed ID: 15388576
[TBL] [Abstract][Full Text] [Related]
14. Plasmacytoid dendritic cells: from the plasmacytoid T-cell to type 2 dendritic cells CD4+CD56+ malignancies.
Béné MC; Feuillard J; Jacob MC;
Semin Hematol; 2003 Jul; 40(3):257-66. PubMed ID: 12876674
[TBL] [Abstract][Full Text] [Related]
15. [Blastic plasmacytoid dendritic cell neoplasm revealed by ecchymotic lesions on the face].
Ahogo KC; Wantz M; Cliquennois M; Gosset P; Lebas D; Modiano P
Ann Dermatol Venereol; 2014 Jan; 141(1):43-7. PubMed ID: 24461094
[TBL] [Abstract][Full Text] [Related]
16. CD4+CD56+CD68+hematopoietic tumor of probable plasmacytoid monocyte derivation with weak expression of cytoplasmic CD3.
Ko YH; Kim SH; Park K; Ree HJ
J Korean Med Sci; 2002 Dec; 17(6):833-9. PubMed ID: 12483012
[TBL] [Abstract][Full Text] [Related]
17. CD123+CD4+CD56+ neoplasm: blastic plasmacytoid dendritic cell neoplasm or acute myeloid leukemia?
Wang W; Thakral B
Blood; 2020 Sep; 136(13):1565. PubMed ID: 32970810
[No Abstract] [Full Text] [Related]
18. Non-B, non-T neoplasms with lymphoblast morphology: further clarification and classification.
Karube K; Ohshima K; Tsuchiya T; Yamaguchi T; Suefuji H; Suzumiya J; Harada M; Kikuchi M
Am J Surg Pathol; 2003 Oct; 27(10):1366-74. PubMed ID: 14508398
[TBL] [Abstract][Full Text] [Related]
19. CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype.
Urosevic M; Conrad C; Kamarashev J; Asagoe K; Cozzio A; Burg G; Dummer R
Hum Pathol; 2005 Sep; 36(9):1020-4. PubMed ID: 16153467
[TBL] [Abstract][Full Text] [Related]
20. CD4+/CD56+ hematodermic neoplasm: presentation of 2 cases and review of the concept of an uncommon tumor originated in plasmacytoid dendritic cells expressing CD123 (IL-3 receptor alpha).
Piña-Oviedo S; Herrera-Medina H; Coronado H; Del Valle L; Ortiz-Hidalgo C
Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):481-6. PubMed ID: 18091395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
